Compass Therapeutics Inc — Cash Flow (NASDAQ:CMPX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 26.8 M19.67 M34.13 M40.62 M44.85 M 45.05 M Cash from investing activities 38 K1.77 M151.2 M26.96 M46.77 M 105.3 M Cash from financing activities 48.54 M118.61 M75.76 M2.94 M17.34 M 128.45 M Free cash flow 26.7 M18.1 M33.91 M40.59 M44.81 M 45.03 M

ニュース

重要ながんデータを控えCompass Therapeuticsの決算発表が迫る

Compass Therapeutics earnings on deck as pivotal cancer data looms

Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?

クレイグ・ハラム、コンパス・セラピューティクスの株式をバイ評価で新規カバレッジ開始

Craig-Hallum initiates coverage on Compass Therapeutics stock with Buy rating

コンパス・セラピューティクス株、クレイグ・ハラムの「買い」評価で上昇

Compass Therapeutics stock rises after Craig-Hallum initiates coverage with Buy

Canaccord Genuity raises Compass Therapeutics stock price target on Phase 2/3 data expectations

Compass Therapeutics stock hits 52-week high at 6.51 USD

Are Medical Stocks Lagging ResMed (RMD) This Year?

Wall Street Analysts See an 113.73% Upside in Compass Therapeutics, Inc. (CMPX): Can the Stock Really Move This High?

コンパス・セラピューティクス株、52週高値の6.25ドルに到達